CMC Vellore to host major gene therapy conference in 2026

Christian Medical College (CMC) in Vellore is set to host a landmark conference dedicated to gene therapy, positioning the institution as a key venue for discussing cutting-edge advances in the field across South Asia.

The conference, designated CGTCON 2026, will convene a diverse range of stakeholders including clinical practitioners, research scientists, pharmaceutical industry representatives, and regulatory authorities. The event aims to facilitate meaningful dialogue and strengthen collaborative networks among these groups, which play critical roles in translating gene therapy innovations from laboratory settings into clinical applications.

Gene therapy has emerged as a transformative area of medical research, offering potential treatments for previously intractable genetic and acquired diseases. By bringing together practitioners, researchers, and industry partners under one platform, the conference seeks to address shared challenges in clinical translation, regulatory frameworks, and patient access.

The timing of the conference reflects growing momentum in India's biotechnology sector and CMC Vellore's position as a leading medical research institution. Such collaborative forums are instrumental in building the infrastructure and consensus needed to advance complex therapeutic modalities across the region.

Further details regarding the conference schedule, registration, and participant categories are expected to be announced in due course.